PHK
CYTK icon

Point72 Hong Kong’s Cytokinetics CYTK Stock Holding History

Point72 Hong Kong’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,345
Closed -$375K – 504
2024
Q1 		$375K Buy
+5,345
New +$413K 0.02% 362
2021
Q4 		– Sell
-13,990
Closed -$500K – 1990
2021
Q3 		$500K Buy
13,990
+4,585
+49% +$135K 0.02% 930
2021
Q2 		$186K Buy
9,405
+8,741
+1,316% +$205K 0.01% 1174
2021
Q1 		$15K Buy
664
+226
+52% +$4.83K ﹤0.01% 1529
2020
Q4 		$9K Buy
+438
New +$8.01K ﹤0.01% 1548
2019
Q4 		– Sell
-153
Closed -$2K – 1214
2019
Q3 		$2K Buy
+153
New +$1.92K ﹤0.01% 861
2018
Q2 		– Sell
-351
Closed -$3K – 941
2018
Q1 		$3K Buy
+351
New +$3.01K ﹤0.01% 762

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Hong Kong's CYTK Position: Q2 2024 in Review

Point72 Hong Kong sold out of Cytokinetics (CYTK) in Q2 2024, closing a stake of 5,345 shares — an estimated $375K sold.

Point72 Hong Kong first reported a position in CYTK in Q1 2018 and held it in 7 quarters. The position peaked at $500K in Q3 2021. 343 funds tracked by Wall St. Rank hold CYTK as of Q2 2024.

  • Point72 Hong Kong reported no remaining Cytokinetics position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 5,345 Cytokinetics shares in Q2 2024, an estimated $375K.
  • Point72 Hong Kong first reported a position in Cytokinetics in Q1 2018 and held it in 7 quarters.
  • Point72 Hong Kong's Cytokinetics position peaked at $500K in Q3 2021.
  • 343 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.